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Peptides with antioxidant and ACE-inhibitory capacities have been obtained from 
a plum (Prunus Domestica L.) by-product by in vitro hydrolysis. The aim of this work 
was to fractionate the most active plum hydrolysates, to identify peptides in these 
fractions, and to evaluate their resistance to gastrointestinal enzymes. Highest antioxidant 
capacity was observed in the whole Alcalase hydrolysate while peptides yielding the 
highest ability to inhibit ACE activity were concentrated in the fraction < 3 kDa from the 
Thermolysin hydrolysate. RP-HPLC-ESI-MS/MS enabled the identification of 13 and 7 
potential antioxidant and antihypertensive peptides, respectively, in these fractions. 
Nevertheless, RP-HPLC alone did not guarantee the successful separation of all peptides. 
The combination of RP-HPLC and hydrophilic interaction liquid chromatography 
(HILIC) coupled to ESI-Q-TOF-MS/MS enabled the identification of all peptides. Five 
potential antioxidant and three potential antihypertensive peptides could be additionally 
identified by HILIC. A total of 7 potential antioxidant peptides and 3 potential 
antihypertensive peptides resisted a simulated gastrointestinal digestion.  
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Fruit residues are one of the main constituents of food industry waste. Most of these 
wastes are discarded causing important environmental pollution and health risks (Deng 
et al., 2012). In other occasions, these by-products are processed into low market-valued 
products such as animal feed (Restrepo Gallego, 2006). New approaches to reuse these 
wastes and obtain high valuable compounds are, nowadays, important trends (Deng et al., 
2012; Duda-Chodak & Tarko, 2007). 
According to the Food and Agricultural Organization (FAO) of the United Nations 
(FAOSTAT, 2015), plum production in Spain in 2013 was about 172 thousand tons, 
which supposes a fiftieth of the plum world production. From this production, about 10 
to 25 % are by-products generated by plum canning and beverage industries (Ros et al., 
2012). Plums (Prunus domestica L.) seeds are by-products with a considerably high 
protein content (around 20%) (Alpers, 1917; Giaja, 1927). Albeit plum seeds are rich in 
highly valuable proteins, they are irretrievably lost since they are considered a useless 
waste. Nevertheless, these proteins could be a cheap source of valuable peptides.  
Bioactive peptides are generally small, with around 2-20 amino acids residues, 
where activity depends mainly on their structure and amino acid composition (Erdmann, 
Cheung, & Schroeder, 2008). Antioxidant peptides are typically rich in highly 
hydrophobic and aromatic amino acids (Erdmann et al., 2008; Sarmadi & Ismail, 2010). 
while antihypertensive peptides usually contain aromatic amino acids as phenylalanine, 
tyrosine, and tryptophan (Erdmann et al., 2008; Jung et al., 2006; Saito, 2008) and/or 
hydrophobic amino acids like proline close to the C-terminal position (Erdmann et al., 
2008; Jung et al., 2006; Ondetti, Sabo, & Cushman, 1980). Identification of peptides has 
been mainly performed using reversed-phase (RP)-HPLC coupled to mass spectrometry 
(Esteve, Marina, & García, 2015; González-García, Marina, & García, 2014). 
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Nevertheless, RP is less effective for the separation of short chain peptides. There has not 
been an attractive alternative to RP for many years for the separation of short chain 
peptides. Hydrophilic interaction liquid chromatography (HILIC) emerged as an 
appealing chromatographic mode for the separation of polar compounds like small size 
peptides (D'Attoma & Heinisch, 2013). HILIC uses hydrophilic stationary phases like 
those traditionally employed in normal phase (NP) (e.g., silica, amino, and cyano) 
(Buszewski & Noga, 2012) and also new specific ones. HILIC mobile phases consist of 
water miscible solvents that are highly compatible with electrospray ionization-mass 
spectrometry (ESI-MS) (Jandera, 2011). Separations are performed by gradient elution 
with increasing concentrations of the aqueous phase. Unlike RP, separation by HILIC 
could involve a partition between the aqueous layer imbibed on the stationary phase and 
the hydrophilic elution buffer. Additionally, electrostatic interactions or hydrogen 
bonding to the stationary phase could also be present. Buffering salts (ammonium acetate 
or formate) are usually added to the mobile phase in order to reduce these electrostatic 
interactions (Bernal, Ares, Pol, & Wiedmer, 2011). 
 In a previous work, proteins from plum seeds were extracted and digested using 
different enzymes and digestion conditions. Results showed that hydrolysates obtained 
with Alcalase and Thermolysin presented, respectively, interesting antioxidant and ACE-
inhibitory capabilities (González-García, García, & Marina, 2014). In the present work, 
we will focus on the fractionation of Alcalase and Thermolysin hydrolysates, the 
comprehensive identification of bioactive peptides in most active fractions using HILIC 
and RP-HPLC coupled to ESI-Q-TOF-MS/MS, and on the evaluation of peptide 




2. Materials and methods 
2.1.Chemicals and samples.  
All chemicals and reagents were of analytical grade. Water was taken daily from a 
Millipore Milli-Q system (Bedford, MA, USA). Acetonitrile (ACN), acetic acid (AA), 
acetone, methanol (MeOH), and hexane were from Scharlau Chemie (Barcelona, Spain). 
Tris(hydroxymethyl)aminomethane (Tris), hydrochloric acid (HCl), sodium dodecyl 
sulfate (SDS), sodium bicarbonate, phosphate buffer, and ammonium acetate were from 
Merck (Darmstadt, Germany). Sodium hydroxide, dithiothreitol (DTT),o-phthalaldehyde 
(OPA), sodium tetraborate, β-mercaptoethanol, glutathione, 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS), potassium persulfate, (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) (Trolox), 1,10-phenantroline, ferrous sulfate, 
hydrogen peroxide, potassium ferricyanide, trichloroacetic acid, ferric chloride, linoleic 
acid, ammonium thiocyanate, ferrous chloride, angiotensin converting enzyme (ACE) 
from rabbit lung, hippuryl-histidyl-leucine, 2-[4-(2-hydroxyethyl)-1-piperazinyl]-
ethanesulfonicacid, sodiumchloride, Thermolysin, pepsin from porcine gastric mucosa 
(P-7012), and pancreatin from porcine pancreas (P-7545) were all purchased at Sigma-
Aldrich (Saint Louis, MO, USA). Alcalase 2.4 L FG was kindly donated by Novozymes 
Spain S.A. (Madrid, Spain). Plums were acquired in a local supermarket in Alcalá de 
Henares (Madrid). 
2.2. Protein extraction, digestion, and ultrafiltration.  
Plum seed proteins were extracted using previously optimized conditions González-
García et al. (2014). Briefly, 0.5 g of ground seeds were defatted three times with 20 mL 
of hexane. Proteins were extracted with 100 mM Tris-HCl buffer (pH 7.5) containing 1 
% (w/w) SDS and 0.25 % (w/w) DTT using a high intensity focused ultrasound probe 
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(model VCX130 from Sonics Vibra-Cell, Hartford, CT, USA) for 1 min at 30% of 
amplitude. After centrifugation, extracted proteins were precipitated with 10 mL of cold 
acetone for 30 min in the fridge. Precipitated proteins were centrifuged (10 min, 4000 x 
g) and redissolved in the appropriate buffer for its further digestion. 
Digestion of proteins was performed with Alcalase or Thermolysin which provided, 
in a previous work González-García et al. (2014), the most antioxidant and ACE-
inhibitory hydrolysates, respectively. Optimized conditions were employed. In the case 
of Alcalase, precipitated proteins were dissolved up to a concentration of 5.0 mg/mL in 5 
mM borate buffer (pH = 8.5) and incubated with the enzyme at an enzyme:substrate ratio 
of 0.30 AU/g protein for 3 h at 50 ºC in a Thermomixer Compact from Eppendorf AG 
(Hamburg, Germany). In the case of Thermolysin, a 5 mM phosphate buffer (pH = 8.0) 
was employed to dissolve proteins at a concentration of 2.5 mg/mL and the solution was 
incubated with the enzyme at a 0.10 g enzyme/g protein for 4 h at 50 ºC. In both cases, 
the digestion was stopped by raising the temperature to 100 ⁰C for 10 min followed by 
centrifugation (5 min, 7000 x g).  
Hydrolysates were fractionated by ultrafiltration (60 min, 7000 x g). For that 
purpose, Vivaspin 500 PES filters with 5 kDa molecular weight cut-off (MWCO) 
(Sartorious Stedim Biotech, Goettingen, Germany) and Amicon filters with 3 kDa 
MWCO (Millipore) were employed. Obtained fractions (> 5 kDa, 3-5 kDa, and < 3 kDa) 
were dissolved to the initial volume with the digestion buffer in order to compare 
antioxidant and ACE-inhibitory capacities with those of the whole hydrolysate. Fractions 
were stored at -20 ⁰C until use. 
2.3. O-phthalaldehyde (OPA) assay. 
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Peptide content was measured using the OPA assay, following the procedure 
described by González-García et al. (2014). Replicates of every sample were measured at 
least three times. 
2.4. In vitro bioactivity assays.  
In vitro antioxidant capacity of hydrolysates and fractions were measured using four 
different assays evaluating: the ability to scavenge free radicals (ABTS and hydroxyl 
radicals), the ability to reduce Fe (III) (Ferric reducing antioxidant power (FRAP) assay), 
and the ability to inhibit lipid peroxidation. Every sample was prepared by triplicate and 
every measurement was done at least three times. Solvent blanks were measured for every 
assay. All assays were carried out following the procedures described by González-García 
et al. (2014). Antioxidant capacity was expressed as percentage of inhibition. 
In vitro antihypertensive capacity was evaluated by measuring the ability to inhibit 
ACE, one of the main enzymes responsible for regulating blood pressure. ACE inhibitory 
capacity of hydrolysates and fractions was measured according to the procedure described 
by González-García et al. (2014). Potential antihypertensive capacity was expressed as 
IC50 which is the peptide concentration needed to inhibit a 50% ACE. 
2.5. Simulated gastrointestinal (GI) digestion.  
Most active peptide fractions were next digested following the method described 
by Puchalska, García, & Marina (2014). Briefly, sample pH was fixed to 2 with 1 M HCl, 
pepsin was added at an enzyme:substrate ratio 1:35, and the mixture was incubated for 1 
h at 37 ⁰C and shaking. After pepsin digestion, sample was adjusted to pH 5 with 0.1 M 
NaHCO3 and to pH 7-8 with 0.1 M NaOH. Pancreatin digestion was carried out in 0.1 M 
phosphate buffer (pH 8) by the addition of the enzyme at an enzyme:substrate ratio 1:25 
for 2 h at 37 ⁰C and shaking. Reaction was stopped by boiling for 10 min. 
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2.6. Analysis by HPLC-MS/MS.  
Samples were analyzed using a Quadrupole-Time-of-Flight (Q-TOF) mass 
spectrometer (instrument series 6530) from Agilent Technologies (Palo Alto, CA, USA) 
coupled to an HPLC system 1100 series also from Agilent Technologies. Separation of 
peptides was carried out through two different modes: Reversed Phase (RP) and 
Hydrophilic Interaction Liquid Chromatography (HILIC). Both columns consisted of 
fused core superficially porous particles. 
The separation by RP mode was performed on an Ascentis Express Peptide ES-C18 
column (100 mm x 2.1 mm I.D., 2.7 μm particle size) with an Ascentis Express guard 
column (5 mm x 2.1 mm I.D., 2.7 μm particle size), both from Supelco (Bellefonte, PA, 
USA). Following chromatographic conditions were used: mobile phase A, water with 0.3 
% (v/v) AA; mobile phase B, ACN with 0.3 % (v/v) AA; elution gradient, 3 % B for 5 
min, 3–25 % B in 30 min, 25–95 % B in 5 min, and 95–3 % B in 2 min; flow rate, 0.3 
mL/min; temperature, 25 ⁰C; injection volume, 15 μL. The separation by HILIC was 
carried out on an Ascentis Express HILIC (100 mm x 2.1 mm, I.D., 2.7 μm particle size) 
column with an Ascentis Express guard column (5 mm x 2.1 mm I.D., 2.7 μm particle 
size), both from Supelco. The chromatographic conditions were: mobile phase A, ACN; 
mobile phase B, water with 50 mM ammonium acetate (pH 7); elution gradient,10–40 % 
B in 20 min, 40 % B for 10 min, and 40–10 % B in 5 min; flow rate, 0.3 mL/min; 
temperature, 25 ⁰C; injection volume, 15 μL. In both modes, UV (210, 254, and 280 nm) 
and MS/MS signals were simultaneously registered. 
The mass spectrometer was operated in the positive ion mode and the mass range 
was from m/z 100 to 1500 Da. ESI conditions were: fragmentator voltage, 200 V; nozzle 
voltage, 0 V; nebulizer pressure, 50 psig; capillary voltage, 3500 V; gas temperature, 350 
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⁰C; gas flow, 12 L/min, and skimmer voltage, 60 V. The Jet Stream sheath gas 
temperature and flow were 400 ⁰C and 12 L/min, respectively. MS/MS was performed 
employing the auto mode and the following optimized conditions: 1 precursor per cycle, 
dynamic exclusion after two spectra (released after 1 min), and collision energy of 5 V 
per 100 Da. 
2.7. Identification of bioactive peptides.  
Tandem MS/MS spectra were obtained for the molecular ion with the highest 
abundance. Every sample was prepared in duplicate and injected in triplicate into the MS 
system. In order to assure that identified peptides came from plum seed proteins, blank 
samples containing everything except plum seed proteins were also analyzed.  
MS/MS spectra were analyzed using PEAKS Studio Version 7 (Bioinformatics 
Solutions Inc., Waterloo, Canada). Analysis of data was performed with the de novo 
sequencing tool. All results were refined applying a certain average local confidence 
(ALC), which is the expected percentage of correct amino acids in the peptide sequence. 
Peptides identified above ALC equal or superior to 90% threshold and with good 
precursor fragmentation pattern, have been treated as a true identification and used in 
further data analysis. Only those peptides appearing in all six injections were taken into 
account. It must be noted that it is not possible to differentiate I from L by MS due to 
their equal molecular masses. Only isoforms with L are presented in our results, although 
peptide sequences containing I amino acid instead of L are also possible. 
Venn diagrams were created employing the GenoTool bioinformatics facility.  
2.8. Statistical analysis 
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Statistical analysis was carried out employing Statgraphics Software Plus 5.1 
(Statpoint Technologies, Inc., Warrenton, VA, USA). In order to find statistically 
significant differences among obtained results, analysis of variance (ANOVA) and t-test 
were applied. 
3. Results and discussion 
Results obtained in a previous study showed that plum seeds were a relevant source 
of antioxidant and ACE-inhibitory peptides (González-García et al., 2014). In that work, 
the extraction of plum seed proteins and their digestion using different enzymes were 
optimized. Alcalase was the enzyme yielding the peptides with the highest antioxidant 
capacity while Thermolysin was the enzyme producing the most potent ACE-inhibitory 
peptides. The aim of this work was to fractionate most active hydrolysates, to 
comprehensively identify the peptides responsible for these abilities using HILIC and RP-
HPLC-ESI-MS/MS, and to evaluate the resistance of most active peptides in a simulated 
gastrointestinal digestion.  
3.1.Selection of most active peptide fractions.  
Alcalase and Thermolysin hydrolysates were fractionated according to their 
molecular masses by ultrafiltration obtaining fractions < 3 kDa, from 3-5 kDa, and > 5 
kDa. The peptide content and antioxidant capacities of the whole Alcalase hydrolysate 
and its fractions were measured and results are presented in Figure 1. Antioxidant 
capacity of extracts was estimated using four different assays covering different 
mechanisms of oxidation inhibition. The highest peptide content was obtained for the 
peptide fraction below 3 kDa, while the lowest was observed for the peptide fraction 
between 3 and 5 kDa. In general, antioxidant capacity was not concentrated in a particular 
peptide fraction observing the highest antioxidant capacity in the whole extract for all 
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assays, with the exception of FRAP one. This behavior is usual (Ghiselli, Serafini, 
Natella, & Scaccini, 2000) within antioxidant compounds since their cooperation is 
responsible of the superior defense against oxidants attack. In fact, antioxidant radicals 
are formed during the inhibition of oxidation and, in order to reduce their reactivity and 
to recover reduced antioxidants, antioxidant systems work in a synergistic way and 
regenerate each other (Vertuani, Angusti, & Manfredini, 2004). The deficiency of a 
component in an antioxidant system can, therefore, affect the efficiency of other. This 
explanation may explain why the peptide fractions showed lower antioxidant capacity 
than that observed for the whole Alcalase hydrolysate. Therefore, identification of 
peptides was carried out in the whole Alcalase hydrolysate. 
 
Figure 1. Peptide content and antioxidant capacity of the whole hydrolysate obtained 
with Alcalase enzyme from plum seed proteins and its fractions (> 5 kDa, 3 - 5 kDa, < 3 




The peptide content and IC50 values against ACE of the whole Thermolysin 
hydrolysate and its fractions are depicted in Figure 2. Results revealed that most peptides 
in the Thermolysin hydrolysate had a molecular mass < 3 kDa. Moreover, almost all 
capacity observed in the whole Thermolysin hydrolysate proceeded from this peptide 
fraction (t-test, p < 0.05). The IC50 value of peptides concentrated in fraction < 3 kDa was 
22.8 µg/mL. If we compare this value with the obtained with known milk peptides VPP 
and IPP (IC50 values of 2.8 μg/mL and 1.7 μg/mL, respectively), we can conclude that the 
ACE inhibiting capacity of peptides in this fraction is high and it could be useful to isolate 
single peptides as IPP and VPP (De Leo, Panarese, Gallerani, & Ceci, 2009). The peptide 
fractions > 5 kDa and 3-5 kDa did not exhibit ACE inhibitor capacity. This behavior was 
expected since ACE inhibiting peptides show short sequences (Puchalska, Marina, & 
García, 2015). Therefore, identification of peptides was carried out in the fraction < 3 
kDa from the hydrolysate obtained with Thermolysin. 
Figure 2. Peptide content and Angiotensin-converting enzyme-inhibitory capacity of the 
whole hydrolysate obtained with Thermolysin enzyme from plum seed proteins and its 




3.2. Identification of peptides in most active fractions by RP-HPLC- and 
HILIC-ESI-Q-TOF-MS/MS.  
In order to identify antioxidant and ACE-inhibitory peptides, most active extracts 
(whole Alcalase hydrolysate and Thermolysin fraction < 3 kDa) were analyzed by HPLC-
ESI-Q-TOF.  
3.2.1. Identification of peptides in the whole Alcalase hydrolysate showing 
the highest antioxidant capacity 
Peptides in the whole Alcalase hydrolysate were identified in a previous work using 
RP-HPLC-ESI-Q-TOF (González-García et al., 2014). Figure 3A shows the total ion 
chromatogram obtained by RP-HPLC. There were 13 different peptides that could be 
identified in the time range from 6 to 28 min. Nevertheless, less hydrophobic peptides, 
eluting at the beginning of the gradient, could not be efficiently separated and were not 
identified. In order to obtain a comprehensive identification of peptides, the whole 
Alcalase hydrolysate was also analyzed by HILIC-ESI-Q-TOF. When HILIC separation 
was carried out, a less crowded chromatogram was observed (see Figure 3B). Sequence, 
ALC, molecular mass, retention time, and mass accuracy of peptides were grouped in 
Table 1. In order to compare these results with those previously obtained by RP-HPLC-
ESI-Q-TOF (González-García et al., 2014) they have also been included in Table 1. 
Peptides in Table 1 are supposed to be those present in a higher concentration and best 
ionized by ESI. A total of 11 peptides with a number of amino acids ranging from 4 to 9 
were identified when using HILIC. Comparison of these peptides with the 13 peptides 
detected by RP-HPLC-MS enabled to observe that 6 peptides (marked by *) were 
simultaneously detected when using both separation modes, that 7 peptides were just 
found when RP-HPLC was used, and that 5 peptides were observed when using just 
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HILIC. Figure 3C also shows the MS/MS spectrum of one of the peptides simultaneously 
observed by RP-HPLC and HILIC. Peptides simultaneously observed by both modes 
eluted within the first half of the HILIC chromatogram while peptides only observed by 
HILIC eluted very late and, thus, they were very hydrophilic. 
 
 
Figure 3.Total ion chromatograms corresponding to the whole Alcalase hydrolysate 
obtained by RP-HPLC (A) and HILIC (B) and MS/MS spectrum of a peptide 
simultaneously observed in both chromatographic modes (C). 
Most sequenced peptides showed molecular masses below 1 kDa. These results are 
rational taking into account the low specificity of Alcalase enzyme. Nevertheless, these 
results contrast with the fact that it was possible to obtain fractions > 5 kDa and from 3 
to 5 kDa. This would suggest that the ultrafiltration was not efficient in the fractionation 
of so small peptides.  
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Table 1. Peptide sequence, retention time, average local confidence (ALC), experimental molecular mass, and mass accuracy of the peptides 
identified in the whole Alcalase hydrolysate (showing antioxidant capacity) and in the < 3 kDa Thermolysin fraction (showing Angiotensin-






























MLPSLPK* 23.2  95 784.4517 0.3 MLPSLPK* 16.2 95 784.4517 1.6 
HLPLL* 26.3 95 591.3744 0.4 KGVL* 19.5 95 415.2794 0.9 
NLPLL* 28.2 95 568.3585 1.2 NLPLL* 2.8 94 568.3585 1.9 
HNLPLL 26.0 95 705.4174 3.1 RALVH 25.3 94 594.3602 1.1 
KGVL* 13.5 94 415.2794 3.8 HLPLL* 8.9 93 591.3744 1.6 
HLPLLR 27.7 94 747.4755 5.8 GFPPK 23.6 93 544.3009 0.3 
HGVLQ* 8.8 93 552.3020 1.7 KGVLY 16.4 93 578.3428 0.4 
GLYSPH 16.1 92 672.3231 3.1 HGVLQ* 14.8 92 552.3020 3.2 
LVRVQ 13.6 92 613.3911 1.6 DQVPR* 20.6 92 613.3184 1.2 
YLSF 25.2 92 528.2584 0.9 NGGK 26.1 91 374.1914 0.4 
DQVPR* 6.1 92 613.3184 3.6 RLPYPLGPN 18.9 91 1025.5658 1.7 
LPLLR 22.7 91 610.4166 4.7      
VKPVAPF 23.7 91 756.4534 3.0      
ACE 
inhibitory 
LYSPH 12.7 97 615.3016 0.7 HLLP 14.3 96 478.2903 2.1 
LYTPH 15.0 97 629.3173 1.3 VVYV* 2.0 95 478.2791 0.5 
VVYV* 21.4 97 478.2791 0.7 LAGNPENE 19.2 93 842.3770 1.0 
LLAQA 17.2 94 514.3115 1.1 LFSPR 12.8 92 618.3489 1.4 
FGEGPY 23.2 93 668.2806 0.9 VLAQ* 4.1 91 429.2587 2.6 
VLAQ* 3.3 91 429.2587 3.1      
VAVNL 24.4 91 514.3115 2.0      
ª Data of antioxidant peptides identified by RP-HPLC-MS/MS were taken from González-García et al. (2014). *Peptides simultaneously 
observed by RP-HPLC and HILIC. 
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 Regardless of the separation mode, the analysis of the amino acid composition of 
identified peptides showed a high amount of hydrophobic and aromatic amino acid 
residues. These are very important and common features among antioxidant peptides 
(Erdmann et al., 2008; Sarmadi & Ismail, 2010). Moreover, the number of hydrophobic 
amino acid residues of peptides detected by HILIC-MS (55%) was lower than the 
observed in the peptides detected by RP-HPLC-MS (66%).  
 Sequenced peptides were checked against BIOPEP (2015) and PeptideDB 
(Bioinformatics Data Resource Catalogue) (2015) bioactive peptide databases. Despite 
some peptides could be found within longer peptides, such as KGVL peptide that was 
previously reported within three longer peptides exerting antibacterial activity 
(Morikawa, Hagiwara, & Nakajima, 1992; Simmaco, Mignogna, Barra, & Bossa, 1994; 
Suzuki, Ohe, Okubo, Kakegawa, & Tatemoto, 1995), most of the peptides have not been 
previously reported. 
3.2.2. Identification of peptides in the Thermolysin fraction < 3 kDa 
showing the highest ACE-inhibitory capacity 
Table 1 also summarizes all ACE-inhibitory peptides identified by RP-HPLC- and 
HILIC-MS/MS. All identified peptides showed molecular masses < 0.9 kDa. A total of 
10 different peptides were observed, 5 of them were present just when using RP-HPLC 
and 3 when employing HILIC. Moreover, 2 peptides were simultaneously detected by 
both separation modes (marked by *). Most peptides contained hydrophobic amino acids 
and aromatic amino acids, which are typical features of ACE inhibitor peptides (Erdmann 
et al., 2008; Jung et al., 2006; Saito, 2008). 
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Identified peptide sequences were searched in BIOPEP (2015) and PeptideDB 
(2015) databases. Peptide VLAQ was found previously within a longer sequence 
(VLAQYK) of an ACE inhibitor peptide (Arihara, 2006) and LLAQA was observed in 
the sequence of different angiotensin-like peptides and defensins. 
3.3.Identification of peptides after gastrointestinal (GI) digestion by RP-
HPLC- and HILIC-ESI-Q-TOF-MS/MS.  
The potential of bioactive peptides depends on their capacity to reach target organs 
in an intact conformation. GI digestion is one of the barriers that peptides have to 
overcome for that purpose. In order to evaluate the resistance of peptides to GI digestion, 
extracts were submitted to a hydrolysis procedure using conditions simulating in vivo 
gastrointestinal digestion. Therefore, whole Alcalase hydrolysate and Thermolysin 
fraction < 3 kDa, that yielded the highest antioxidant and ACE-inhibitory capacities, 
respectively, were sequentially hydrolysed using pepsin (endopeptidase acting at stomach 
level) and pancreatin (mixture of trypsin, α-chymotrypsin, elastase, and carboxipeptidase 
A and B, acting at intestinal level) enzymes.  
The antioxidant capacity and peptide content of the whole Alcalase hydrolysate 
after simulated GI digestion were evaluated. As expected, the peptide content increased 
(around 25%) due to further digestion with pepsin and pancreatin. Nevertheless, the 
antioxidant capacity did not change significantly (p > 0.05), from 57.6 ± 4.3 to 52.7 ± 4.2 
% inhibition of ABTS radical. Similarly, the peptide content of the Thermolysin fraction 
< 3 kDa also yielded an increase (around 32%) after GI digestion. Although GI digestion 
did significantly decrease ACE inhibitory capacity (p < 0.05), it was still kept at a high 
level observing an IC50 = 30 ± 3 µg/mL. 
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In order to identify antioxidant and ACE-inhibitory peptides resisting GI digestion, 
obtained extracts were again analyzed by HPLC-ESI-Q-TOF system under exactly the 
same conditions used previously.  
3.3.1. Identification of peptides in the whole Alcalase hydrolysate after GI 
digestion 
 The analysis of the whole Alcalase hydrolysate after the GI digestion revealed the 
presence of 14 different peptides: 9 were separated by RP-HPLC, 3 were separated by 
HILIC, and 2 were observed by both modes (NLPLL and HGVLQ). Summary of 
identified peptides is presented in Table 2. Peptides showed molecular masses below 0.8 
kDa.  
All identified peptides were checked against BIOPEP (2015) and PeptideDB (2015) 
databases. Peptide LPLL, only observed by RP-HPLC, was found within various longer 
sequences of antibacterial (Amiche, Seon, Pierre, & Nicolas, 1999; Park, Jung, & Lee, 
1994; Saberwal & Nagaraj, 1994) peptides. 
Peptides identified in the whole Alcalase hydrolysate of plum seed proteins, before 
and after the GI digestion were compared. Results (see Figure 4A) highlighted 7 peptides 
resisting GI digestion: 3 peptides only observed by RP-HPLC, 2 just detected when using 
HILIC, and 2 peptides observed by both modes. Most of these resisting peptides contained 
proline in their sequences which makes them less susceptible to further proteolysis 
(Escudero, Angel Sentandreu, & Toldra, 2010). Additionally, 8 peptides, not observed 
before GI digestion, were also identified. Peptide LPLL appeared in the Alcalase enzyme 
sequence although it was not observed among peptides identified in the Alcalase digestion 
autolysis blank. Therefore, this peptide was not discarded since it could proceed from 
peptides detected previously to the gastrointestinal digestion (e.g., HNLPLL, HLPLLR, 
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HLPLL, NLPLL or LPLLR). Indeed, this peptide could probably be formed by pepsin 
digestion since this enzyme generates peptides containing L at N-terminal position 
(Savoie, Gauthier, Marin, & Pouliot, 2005). Another example is the peptide NLPL that 
could come from HNLPLL. In other cases, original peptides are not included in the list of 
identified peptides but they could come from other less abundant or non-ionized peptides. 
For example, pepsin that often generates peptides with Y, F, and L at N-terminal position 
(Savoie et al., 2005) and /or M, F, and L at C-terminal position (Escudero et al., 2010) 
could have produced LSVVN, DGDPL, LPAGV, and LYTPH peptides; trypsin that 
generates peptides with K or R at C-terminal position could have produced NGGGK 
peptide, and elastase, that specifically cleavages peptide bonds at C-terminal position of 
G, A, and V, could have resulted in LPAGV peptide. 
 
Figure 4. Venn diagrams 
comparing the peptides identified 
before and after simulated 
gastrointestinal digestion (GI) 
digestion by HPLC-Q-TOF-
MS/MS in (A) the whole Alcalase 
hydrolysate and (B) the fraction < 





Table 2. Peptide sequence, retention time, average local confidence (ALC), experimental molecular mass, and mass accuracy of the peptides 
identified in the whole Alcalase hydrolysate (showing antioxidant capacity) and in the < 3 kDa Thermolysin fraction (showing Angiotensin-






























LSVVN 18.9 94 530.3064 1.0 NLPLL* 3.3 95 568.3585 2.7 
MLPSLPK 26.2 94 784.4517 1.2 NGGGK 27.1 95 431.2128 2.9 
LPLL 30.2 94 454.3155 2.3 APGAGV 17.1 94 470.2489 1.0 
HLPLL 35.6 93 591.3744 1.3 NGGK 26.5 93 374.1914 3.3 
KGVL 5.1 93 415.2794 0.6 HGVLQ* 14.3 92 552.3020 2.0 
DGDPL 16.7 93 515.2227 2.5 DQVPR 20.2 92 613.3184 1.6 
LPAGV 20.5 93 455.2744 1.7      
NLPLL* 31.4 93 568.3585 3.6      
LYTPH 16.9 92 629.3173 1.2      
HGVLQ* 3.6 91 552.3020 0.8      
NLPL 25.9 91 455.2744 2.3      
ACE 
inhibitory 
LYSPH 10.3 97 615.3016 1.6 LAGNPENE 17.9 94 842.3770 2.0 
LLNDE 11.1 97 602.2911 1.8      
LYTPH 17.2 95 629.3173 3.0      
FDAVGVK 21.8 95 734.3962 2.6      
LLYQ 21.6 92 535.3006 1.6      
DQVPR 17.1 91 613.3184 1.1      
 *Peptides simultaneously observed by RP-HPLC-MS/MS and HILIC-MS/MS. 
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3.3.2. Identification of peptides in the Thermolysin fraction < 3 kDa after 
GI digestion 
Peptides identified in the Thermolysin fraction < 3 kDa after GI digestion were 
grouped in Table 2. Results showed seven peptides when using RP-HPLC and one 
peptide only observed by HILIC. No peptide was simultaneously observed by both 
chromatographic modes. Search against BIOPEP (2015) and PeptideDB (2015) databases 
showed that the peptide LLYQ had been previously reported within the sequence of an 
ACE inhibitor (LLYQQPV) (Meisel, Walsh, Murray, & Fitzgerald, 2006) peptide and an 
immunomodulating (LLYQEPVLGPVRGPFPIIV) (Hayes, Stanton, Fitzgerald, & Ross, 
2007) peptide. Again, peptides identified before and after GI digestion were compared 
(see Figure 4B). Three peptides could resist GI digestion: LYSPH and LYTPH, observed 
by RP-HPLC, and LAGNPENE, showed when using HILIC. All three peptides contained 
P within their sequences which could justify their resistance to GI digestion. Moreover, 
three additional peptides, not observed before GI digestion, were now sequenced. Peptide 
DQVPR was also identified in the whole Alcalasa hydrolysate. This peptide could have 
resulted from the digestion with trypsin. Other peptides, such as LLNDE or LLYQ, could 
result from the digestion with pepsin (Savoie et al., 2005). Since ACE-inhibitory capacity 
decreased after GI digestion, additional peptides appearing after GI digestion probably 
showed a lower ACE-inhibitory capacity or were in a lower concentration. 
4. Conclusions 
Peptides fractions showing highly antioxidant and ACE inhibiting peptides have 
been obtained from a plum by-product by in vitro digestion with Alcalase and 
Thermolysin, respectively. No fraction obtained by ultrafiltration showed an antioxidant 
capacity as high as the observed value for the whole hydrolysate obtained with Alcalase 
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enzyme. Most ACE inhibiting peptides obtained by digestion with Thermolysin were 
concentrated in the fraction containing peptides below < 3 kDa. The use of both RP-
HPLC-MS/MS and HILIC-MS/MS guaranteed a comprehensive identification of all 
peptides in both bioactive fractions. The number of identified peptides by RP-HPLC-
MS/MS increased from 13 to 18, in the antioxidant fraction, and from 7 to 10, in the ACE 
inhibiting fraction, when both RP-HPLC and HILIC were employed. When most active 
fractions were submitted to a simulated gastrointestinal digestion, antioxidant capacity 
was maintained while ACE-inhibitory capacity slightly decreased. There were seven 
peptides in the antioxidant extract and three peptides in the ACE inhibiting fraction that 
resisted GI digestion. This work demonstrates that plum seeds are cheap sources of highly 
antioxidant and ACE inhibiting peptides and that this can be an attractive approach to 
reuse this by-product.   
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